Astec LifeSciences Limited — Credit Ratings, 24-03-2025: Credit Rating- New

ICRA Limited has assigned an "[ICRA]AA-(Negative)" rating to Astec LifeSciences' ₹50 Crore Non-Convertible Debenture (NCD) programme. This rating indicates a strong credit quality but reflects potential risks that could affect the company's financial outlook. The rating will remain effective throughout the life of the instrument unless a revision is warranted by new information. Investors should be aware that while the company has a solid rating, the negative outlook suggests caution, and they should monitor any developments closely that could impact debt servicing or operational stability.